Insulin detemir Pregnancy and Breastfeeding Warnings
Insulin detemir is also known as: Levemir
Insulin detemir Pregnancy Warnings
Insulin detemir has been assigned to pregnancy category B by the FDA. A clinical study of pregnant women with type I diabetes using insulin detemir during pregnancy did not show an increase in the risk of fetal abnormalities. Insulin is the drug of choice for the treatment of diabetes during pregnancy. Data from human pregnancy have revealed an increased incidence of teratogenicity associated with diabetes mellitus. The association with the use of insulin is probably coincidental. Because of the strong association between diabetes or hyperglycemia and perinatal morbidity and multiple congenital malformations, most experts recommend strict control of maternal plasma glucose with the use of insulin during pregnancy. Insulin detemir is only recommended for use during pregnancy when benefit outweighs risk.
Insulin detemir Breastfeeding Warnings
There are no data on the excretion of insulin detemir into human milk. The manufacturer recommends that caution be used when administering insulin detemir to breast-feeding women. Lactating women may require an adjustment in insulin dosage and/or diet.
See Also...
- insulin detemir cartridges Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
